Weatherden Symposium 2026

​Women’s health is one of the largest underdeveloped opportunities in life sciences and the scientific, clinical and commercial infrastructure supporting innovation in this space has historically lagged disease burden. Therapeutic areas such as obesity and oncology, fields once considered scientifically complex or commercially uncertain, have become established areas of investment once biological understanding, clinical development strategy, and regulatory pathways mature. Women’s health is now approaching a similar inflection point.

​Weatherden is convening leaders from across biotechnology, pharma, investment and academia to explore how smarter clinical development and regulatory strategy can unlock the next wave of innovation in women’s health.

​This event will bring together leaders from across the ecosystem to explore how the thoughtful application of development strategies utilised in more established therapeutic areas can unlock both clinical impact and commercial viability, and reframe women’s health as a central, scalable, and scientifically rigorous domain.

​Expert panellists will include biopharma leaders who are actively shaping the development and commercialisation of next-generation therapies in women’s health.

​We are currently inviting expressions of interest for a limited number of places at this curated session. Given the interactive format, attendance will be confirmed following review of registrations.

​If you would like to be considered, please register your interest.